Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis
BackgroundThe incidence of DLBCL in elderly patients has been gradually increased. Considering their comorbidities and performance status, the first-line standard treatment hasn’t been determined for the elderly.MethodsWe performed a systemic review and network meta-analysis to compare the efficacy...
Main Authors: | Yangyang Wang, Xiyang Ren, Keke Huang, Xue Liang, Lianfang Pu, Linhui Hu, Zhimin Zhai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1082293/full |
Similar Items
-
Rituximab for primary cutaneous large B-cell non-Hodgkin's lymphoma of the scalp
by: Čolović Nataša, et al.
Published: (2008-01-01) -
Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
by: Sotirios G. Papageorgiou, et al.
Published: (2022-04-01) -
In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies
by: Matylda Kubacz, et al.
Published: (2022-12-01) -
New Frontiers in Monoclonal Antibodies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
by: Mattia Schipani, et al.
Published: (2023-12-01) -
Antibody Therapies for Large B-Cell Lymphoma
by: Novo M, et al.
Published: (2021-05-01)